181
Dianthus Therapeutics, Inc. /DE/
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
82.0
FY23:
177
FY24:
281
FY25:
409
(positive)
Change from FY21 to FY25
millions USD
FY21:
9.24
FY22:
1.08
FY23:
1.95
FY24:
93.1
FY25:
121
Total assets
Change from FY21 to FY25
millions USD
FY21:
190
FY22:
83.1
FY23:
179
FY24:
374
FY25:
531
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
10.9
FY22:
8.23
FY23:
9.63
FY24:
18.5
FY25:
30.7
(negative)
Change from FY21 to FY25
millions USD
FY21:
6.40
FY22:
1.23
FY23:
0.90
FY24:
3.08
FY25:
6.79
(positive)
Change from FY21 to FY25
millions USD
FY21:
173
FY22:
−44.4
FY23:
169
FY24:
352
FY25:
493
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
190
FY22:
–
FY23:
179
FY24:
374
FY25:
531
All amounts in millions USD